Use of tumor necrosis factor-α (TNF-α) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients

✍ Scribed by Sophia Li; Primal P. Kaur; Virginia Chan; Steven Berney

• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 102 KB
• Volume: 28
• Category: Article
• ISSN: 0770-3198
• DOI: 10.1007/s10067-009-1149-4